ChemBriefIndian drugmaker Cipla's Q1 profit misses estimates
Cipla's Q1 profit fell 39.2% to 7.89 billion rupees, missing estimates due to muted generic cancer drug sales and supply disruptions affecting lanreotide in its U.S. business.
reuters · 2026-07-22 23:40